Lifevantage PE Ratio 2010-2024 | LFVN

Current and historical p/e ratio for Lifevantage (LFVN) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lifevantage PE ratio as of March 03, 2025 is 23.38.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Lifevantage PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-02-28 17.17 30.66
2024-12-31 17.53 $0.56 31.30
2024-09-30 12.05 $0.32 37.65
2024-06-30 6.37 $0.23 27.71
2024-03-31 5.97 $0.28 21.34
2023-12-31 5.90 $0.23 25.63
2023-09-30 6.30 $0.20 31.51
2023-06-30 3.99 $0.20 19.95
2023-03-31 3.27 $-0.06 0.00
2022-12-31 3.36 $-0.05 0.00
2022-09-30 3.36 $0.04 84.02
2022-06-30 3.87 $0.24 16.12
2022-03-31 4.20 $0.70 6.00
2021-12-31 5.58 $0.73 7.64
2021-09-30 5.98 $0.98 6.10
2021-06-30 6.49 $0.90 7.21
2021-03-31 8.25 $0.81 10.19
2020-12-31 8.23 $0.80 10.29
2020-09-30 10.66 $0.84 12.69
2020-06-30 11.94 $0.79 15.11
2020-03-31 9.09 $0.79 11.51
2019-12-31 13.78 $0.80 17.23
2019-09-30 12.10 $0.56 21.60
2019-06-30 11.46 $0.50 22.92
2019-03-31 12.62 $0.45 28.04
2018-12-31 11.64 $0.45 25.88
2018-09-30 9.70 $0.41 23.66
2018-06-30 5.62 $0.41 13.72
2018-03-31 3.19 $0.21 15.18
2017-12-31 4.20 $0.09 46.69
2017-09-30 3.73 $0.09 41.40
2017-06-30 3.82 $0.11 34.75
2017-03-31 4.74 $0.26 18.23
2016-12-31 7.20 $0.33 21.80
2016-09-30 8.35 $0.42 19.89
2016-06-30 12.01 $0.42 28.59
2016-03-31 8.03 $0.26 30.90
2015-12-31 8.40 $0.26 32.33
2015-09-30 5.01 $0.22 22.75
2015-06-30 3.28 $0.49 6.69
2015-03-31 4.88 $0.63 7.75
2014-12-31 8.03 $0.70 11.48
2014-09-30 7.05 $0.84 8.39
2014-06-30 8.90 $0.70 12.72
2014-03-31 8.10 $0.56 14.46
2013-12-31 10.20 $0.63 16.19
2013-09-30 14.71 $0.42 35.04
2013-06-30 14.34 $0.42 34.15
2013-03-31 14.52 $0.70 20.75
2012-12-31 13.53 $0.14 96.67
2012-09-30 21.20 $0.49 43.27
2012-06-30 17.49 $0.42 41.64
2012-03-31 23.24 $-3.78 0.00
2011-12-31 8.84 $-4.34 0.00
2011-09-30 9.27 $-4.27 0.00
2011-06-30 9.27 $-4.34 0.00
2011-03-31 4.39 $-0.98 0.00
2010-12-31 2.41 $-1.05 0.00
2010-09-30 3.09 $-1.54 0.00
2010-06-30 3.15 $-1.47 0.00
2010-03-31 2.41 $-1.68 0.00
2009-12-31 1.55 $-1.54 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.211B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Pro-Dex (PDEX) United States $0.108B 16.47